JP2007521799A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007521799A5 JP2007521799A5 JP2006538755A JP2006538755A JP2007521799A5 JP 2007521799 A5 JP2007521799 A5 JP 2007521799A5 JP 2006538755 A JP2006538755 A JP 2006538755A JP 2006538755 A JP2006538755 A JP 2006538755A JP 2007521799 A5 JP2007521799 A5 JP 2007521799A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- compound
- gene expression
- expression pattern
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51807303P | 2003-11-07 | 2003-11-07 | |
| US60/518,073 | 2003-11-07 | ||
| US57224704P | 2004-05-18 | 2004-05-18 | |
| US60/572,247 | 2004-05-18 | ||
| PCT/EP2004/012572 WO2005045044A2 (en) | 2003-11-07 | 2004-11-05 | Use of fibroblast growth factor fragments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007521799A JP2007521799A (ja) | 2007-08-09 |
| JP2007521799A5 true JP2007521799A5 (https=) | 2007-12-13 |
| JP5118851B2 JP5118851B2 (ja) | 2013-01-16 |
Family
ID=34576820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538755A Expired - Fee Related JP5118851B2 (ja) | 2003-11-07 | 2004-11-05 | 線維芽細胞増殖因子フラグメントの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20090093398A1 (https=) |
| EP (1) | EP1682665B1 (https=) |
| JP (1) | JP5118851B2 (https=) |
| AT (1) | ATE507296T1 (https=) |
| DE (1) | DE602004032457D1 (https=) |
| ES (1) | ES2365852T3 (https=) |
| WO (1) | WO2005045044A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
| US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
| US7294704B2 (en) | 2003-08-15 | 2007-11-13 | Diadexus, Inc. | Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
| US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
| JP2006347979A (ja) * | 2005-06-17 | 2006-12-28 | National Institute Of Advanced Industrial & Technology | 創傷治療及び／又は創傷治癒促進のための薬剤 |
| EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
| US11308462B2 (en) | 2014-05-13 | 2022-04-19 | Clear Token Inc | Secure electronic payment |
| JP6232689B2 (ja) | 2015-06-25 | 2017-11-22 | 株式会社国際電気通信基礎技術研究所 | 多器官連関システムを基盤とした予測装置、及び予測プログラム |
| CN114594268A (zh) | 2016-03-29 | 2022-06-07 | 无限生物制药公司 | 用以预防或治疗肾脏疾病的活性组分的候选物质的筛选装置和筛选方法 |
| EP3466446B1 (en) | 2016-03-29 | 2023-12-27 | Karydo Therapeutix, Inc. | Pharmaceutical composition or food composition, and method for assessing effect of active ingredient in vivo |
| WO2021075535A1 (ja) * | 2019-10-18 | 2021-04-22 | 国立大学法人滋賀医科大学 | 異常幹細胞を標的とする糖尿病治療 |
| US20230382966A1 (en) * | 2020-10-27 | 2023-11-30 | Indiana University Research And Technology Corporation | Novel klotho interaction site in the c-terminus of fgf23 |
| CN114940990B (zh) * | 2022-06-20 | 2023-03-14 | 北京市神经外科研究所 | 与颅内动脉瘤相关的基因突变位点及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001249125A1 (en) * | 2000-03-08 | 2001-09-17 | Chiron Corporation | Human fgf-23 gene and gene expression products |
| US20030105302A1 (en) * | 2000-03-08 | 2003-06-05 | Nobuyuki Itoh | Human FGF-23 gene and gene expression products |
| ES2340662T3 (es) * | 2000-07-19 | 2010-06-08 | Advanced Research And Technology Institute | Factor de crecimiento de fibroblastos (fgf23) nuevo procedimiento para el uso. |
| AU2002214286A1 (en) * | 2000-11-15 | 2002-05-27 | Akiko Itai | Method of profiling protein |
| JP2002223753A (ja) * | 2001-01-30 | 2002-08-13 | Hitachi Ltd | 薬物応答解析用オリゴヌクレオチドアレイ |
| CA2443719A1 (en) * | 2001-04-26 | 2002-11-07 | Geneprot, Inc. | Human fibroblast growth factor-related compositions |
| EP1491628A4 (en) * | 2002-03-29 | 2006-10-18 | Nat Inst Of Advanced Ind Scien | NEW GALACTOSTRANSFERASES, PEPTIDES AND THESE CODING NUCLEIC ACID |
| JPWO2003091427A1 (ja) * | 2002-04-24 | 2005-09-02 | 関西ティー・エル・オー株式会社 | 近位尿細管に発現する腎疾患関連遺伝子群 |
-
2004
- 2004-11-05 WO PCT/EP2004/012572 patent/WO2005045044A2/en not_active Ceased
- 2004-11-05 EP EP04797676A patent/EP1682665B1/en not_active Expired - Lifetime
- 2004-11-05 JP JP2006538755A patent/JP5118851B2/ja not_active Expired - Fee Related
- 2004-11-05 DE DE602004032457T patent/DE602004032457D1/de not_active Expired - Lifetime
- 2004-11-05 US US10/578,470 patent/US20090093398A1/en not_active Abandoned
- 2004-11-05 AT AT04797676T patent/ATE507296T1/de not_active IP Right Cessation
- 2004-11-05 ES ES04797676T patent/ES2365852T3/es not_active Expired - Lifetime
-
2011
- 2011-06-03 US US13/152,750 patent/US20120028896A1/en not_active Abandoned
-
2012
- 2012-10-19 US US13/656,084 patent/US20130040882A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fan et al. | Rapid transport of insulin to the brain following intranasal administration in rats | |
| JP2007521799A5 (https=) | ||
| Logan et al. | Decorin attenuates gliotic scar formation in the rat cerebral hemisphere | |
| JP2003505075A5 (https=) | ||
| JP6921755B2 (ja) | 脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物 | |
| Hao et al. | The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats | |
| Kwong et al. | Chronic smoking enhances tachykinin synthesis and airway responsiveness in guinea pigs | |
| JP2017501381A5 (https=) | ||
| CN111228464A (zh) | 广谱抗冠状病毒的多肽及其用途 | |
| JP2001511456A (ja) | 神経学的欠損を治療する方法 | |
| JP2006518991A5 (https=) | ||
| CN113667748A (zh) | circIKBKB的抑制剂及其检测试剂在乳腺癌骨转移诊断、治疗和预后试剂盒的应用 | |
| AU2024201372A1 (en) | Drug target of idiopathic pulmonary fibrosis | |
| CN110256574A (zh) | 融合多肽及在制备抗抑郁、神经退行性疾病药物中的应用 | |
| AU2002341938B2 (en) | Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease | |
| CN121337989A (zh) | 靶向刺激免疫分子在制备治疗器官纤维化疾病药物的用途 | |
| AU2002341938A1 (en) | Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease | |
| Yao et al. | Suppression of asparaginyl endopeptidase attenuates breast cancer-induced bone pain through inhibition of neurotrophin receptors | |
| CN107428811B (zh) | 用于治疗和/或诊断阿尔茨海默氏痴呆症的特异性结合A-β-物类的肽 | |
| KR102146047B1 (ko) | 종양 억제 유전자 ｐｉｐ４ｋ２ａ 및 그의 용도 | |
| Nyström et al. | The role of fibroblasts in dystrophic epidermolysis bullosa pathogenesis and current treatment approaches | |
| Grandis et al. | The role of peptide growth factors in head and neck carcinoma | |
| CN111139299B (zh) | Josd2蛋白在制备治疗恶性肿瘤药物中的应用 | |
| JP2004533235A5 (https=) | ||
| Peng et al. | Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways |